We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

AMSBIO & Sanguine Biosciences Announce Distribution Agreement

News   Aug 23, 2013

 
AMSBIO & Sanguine Biosciences Announce Distribution Agreement
 
 
 

RELATED ARTICLES

Neurofilament Light Change Dynamics: Alzheimer's Diagnostics Progress

News

A simple blood test reliably detects signs of brain damage in people on the path to developing Alzheimer’s disease – even before they show signs of confusion and memory loss, according to a new study from Washington University School of Medicine in St. Louis and the German Center for Neurodegenerative Diseases in Germany.

READ MORE

New Biomarkers Detect 70% of Pancreatic Cancer, a Vast Improvement

News

A new approach to pancreatic cancer screening may help doctors detect the disease in people at high risk before it reaches more advanced and difficult-to treat stages.

READ MORE

Burn Severity Could be Determined from Blister Fluid

News

Researchers have found another, possibly more accurate way to classify burn severity to determine the best course of treatment: analyzing proteins in blister fluid.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE